Cathay Global Genomics Immunology and Medical Revolution ETF (00898.TW) Price
Cathay Global Genomics Immunology and Medical Revolution ETF Price
Cathay Global Genomics Immunology and Medical Revolution ETF List of Holdings
Frequently asked questions about Cathay Global Genomics Immunology and Medical Revolution ETF
Cathay Global Genomics Immunology and Medical Revolution ETF is offered by Cathay, a leading player in the field of passive investments.
The ISIN of Cathay Global Genomics Immunology and Medical Revolution ETF is TW0000089804.
The total expense ratio of Cathay Global Genomics Immunology and Medical Revolution ETF is 1.05%, which means that investors pay 105.00 TWD per 10,000 TWD in investment capital annually.
The ETF is listed in TWD.
European investors may incur additional costs for currency exchange and transaction fees.
No, Cathay Global Genomics Immunology and Medical Revolution ETF does not comply with the EU UCITS investor protection directives.
The P/E ratio of Cathay Global Genomics Immunology and Medical Revolution ETF is 17.66.
Cathay Global Genomics Immunology and Medical Revolution ETF tracks the performance of the Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net.
Cathay Global Genomics Immunology and Medical Revolution ETF is domiciled in TW.
The fund was launched on 11/22/2021.
The Cathay Global Genomics Immunology and Medical Revolution ETF mainly invests in Healthcare companies.
The NAV of Cathay Global Genomics Immunology and Medical Revolution ETF amounts to 8.22 M TWD.
The price-to-book ratio is 3.39.
Investments can be made through brokers or financial institutions that provide access to trading ETFs.
The ETF is traded on the stock exchange, similar to stocks.
Yes, the ETF can be held in a regular securities account.
The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.
The ETF is valued on a daily stock exchange basis.
Information on dividends should be requested from the provider's website or your broker.
The risks include market fluctuations, currency risks, and the risk associated with smaller companies.
The ETF is obligated to report regularly and transparently on its investments.
The performance can be viewed on Eulerpool or directly on the provider's website.
Further information can be found on the official website of the provider.
ETF profile
Cathay Global Genomics Immunology and Medical Revolution ETF